Drug Trial Radar · NCT01284556
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Last checked: Nov 19, 2026Latest source record: Nov 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
314
Actual
Start
Nov 2010
Primary completion
Jan 2013
Study completion Apr 2016
Sponsor
- Lead sponsor
- West-Ward PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Jan 27, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 17 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary: \- to evaluate the efficacy of phenobarbital in reducing seizure frequency. Secondary: * to confirm dose response relationship, * to assess the effects on Type I seizures, * to assess the safety of phenobarbital * to assess the drug tolerability.
Conditions
- Epilepsy
Interventions
PhenobarbitalDrug
tablet
Placebo tabletDrug
tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the efficacy of OD administration of 60 mg and 100 mg phenobarbital in reduction of seizure frequencyTime frame: 34 weeks with maximum 22-week exposure to phenobarbital
Locations
4 sites in 2 countries. Site status is shown where the registry gives one.
Bluegrass Epilepsy Research
Lexington, Kentucky
Lynn Health Science Institute
Oklahoma City, Oklahoma
Centro Neurodiagnostico
Rio Piedras, Puerto Rico
Hospital Del Maestro
San Juan, PR, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.